Send mail to Author

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer : results of the PELICAN study (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___     _    _     _____    _    _    _    _   
 /_   _//   / _ \\  | |  | ||  |  ___|| | |  | || | || | || 
   | ||    | / \ || | |/\| ||  | ||__   | |/\| || | || | || 
  _| ||    | \_/ || |  /\  ||  | ||__   |  /\  || | \\_/ || 
 /__//      \___//  |_// \_||  |_____|| |_// \_||  \____//  
 `--`       `---`   `-`   `-`  `-----`  `-`   `-`   `---`
 


Back to frontdoor view

OPUS4 Logo